O-GlcNAcase Reaction Buffer 10X

• Description:

  O-GlcNAcase Reaction Buffer 10X_x000D_ Catalog number: B2019368_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mL_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: RT_x000D_ Keywords: O-GlcNAcase Reaction Buffer 10X_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Knapp S, Abdo M, Ajayi K, Huhn RA, Emge TJ, Kim EJ, Hanover JA. Tautomeric modification of GlcNAc-thiazoline Org Lett. 2007 Jun 7;9(12):2321-4._x000D_ 2: Elbatrawy AA, Kim EJ, Nam G. O-GlcNAcase: Emerging Mechanism, Substrate Recognition and Small-Molecule Inhibitors ChemMedChem. 2020 Jul 20;15(14):1244-1257._x000D_ 3: Kamemura K. Enzymatic assay of nucleocytoplasmic O-linked β-N-acetylglucosaminidase (O-GlcNAcase) 2021 Sep 23 [updated 2022 Mar 16]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–._x000D_ 4: Bartolomé-Nebreda JM, Trabanco AA, Velter AI, Buijnsters P. O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer's disease and related tauopathies: analysis of the patent literature Expert Opin Ther Pat. 2021 Dec;31(12):1117-1154._x000D_ 5: Chang YH, Weng CL, Lin KI. O-GlcNAcylation and its role in the immune system J Biomed Sci. 2020 Apr 29;27(1):57._x000D_ 6: Muha V, Fenckova M, Ferenbach AT, Catinozzi M, Eidhof I, Storkebaum E, Schenck A, van Aalten DMF. O-GlcNAcase contributes to cognitive function in Drosophila J Biol Chem. 2020 Jun 26;295(26):8636-8646._x000D_ 7: Nagel AK, Ball LE. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity Amino Acids. 2014 Oct;46(10):2305-16._x000D_ 8: Permanne B, Sand A, Ousson S, Nény M, Hantson J, Schubert R, Wiessner C, Quattropani A, Beher D. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies ACS Chem Neurosci. 2022 Apr 20;13(8):1296-1314._x000D_ 9: Alonso J, Schimpl M, van Aalten DM. O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling? J Biol Chem. 2014 Dec 12;289(50):34433-9._x000D_ 10: Sombutthaweesri T, Wu S, Chamusri N, Settakorn J, Pruksakorn D, Chaiyawat P, Sastraruji T, Krisanaprakornkit S, Supanchart C. Relationship Between O-GlcNAcase Expression and Prognosis of Patients With Osteosarcoma Appl Immunohistochem Mol Morphol. 2022 Jan 1;30(1):e1-e10. _x000D_ _x000D_ Products Related to O-GlcNAcase Reaction Buffer 10X can be found at Chemicals

• Short Description:

  Catalog Number: B2019368 (1 mL)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5